Wijziging van de Geneesmiddelenwet ter implementatie van richtlijn 2011/62/EU om te verhinderen dat vervalste geneesmiddelen in de legale distributieketen belanden

This procedure concerns changes to the Medicines Act to implement an EU directive. The goal is to prevent counterfeit medicines from entering the legal distribution chain, ensuring public health and safety. This affects pharmaceutical companies, distributors, and ultimately, patients. It aims to strengthen controls and traceability within the medicine supply network.